Developer docs
API playgroundTry for free, no card

Search company profiles

Clue

Full company profile

uuid000049b

Namestring
Clue
Legal namestring
BioWink GmbH
Websiteurl
helloclue.com
Company typeenum
Private
Founded yearint
2012
Descriptiontext

Clue (legally BioWink GmbH, headquartered in Berlin, Germany) is a femtech company that operates one of the world's largest female health applications for period, fertility, pregnancy, and perimenopause tracking, with reported 100M+ downloads across 190+ countries and 23 languages. The platform is built around a single iOS/Android app with mode-based experiences (Period, Conceive, Pregnancy, Perimenopause, No-Period) plus an FDA-cleared digital contraceptive called Clue Birth Control and a CE-marked fertility algorithm in Clue Conceive, all backed by clinically validated predictive models and an in-app encyclopedia authored with OB/GYNs and certified fertility nurses. The technical stack runs on AWS EU servers under strict GDPR compliance, with health and personal data stored separately, no-sell/no-share-of-health-data guarantees, and de-identified data feeding research collaborations with Oxford, Berkeley, MIT, Stanford, and the Bill & Melinda Gates Foundation. The wearable layer ingests skin temperature and sleep data from 11+ OEM partners including Oura, Withings, WHOOP, Ultrahuman, Huawei, Polar, Fitbit, Luna, Noise, Apple Health, and Google Health Connect.

Clue's revenue model is freemium-led: the free Clue app serves as a top-of-funnel conversion driver into Clue Plus, a monthly subscription sold via App Store, Play Store, and helloclue.com (processed through Paddle) that unlocks advanced cycle insights, multiple tracking modes, Clue Connect partner sharing, and expert content. Paid acquisition extends beyond direct-to-consumer through three emerging B2B2C and channel-revenue streams: insurance-covered distribution via German private health insurer SDK and Stuttgarter Lebensversicherung (~680,000 fully insured members), pre-tax HSA/FSA payments via Flex in the US, and embedded NHS-funded contraception via Evaro in the UK. Brand and research partnerships (L'Oréal, the Women's Health Visibility Alliance with Essity/Hertility/Daye/Mooncup) and wearable OEM co-marketing (e.g., HUAWEI WATCH FIT 5 three-month trial) layer additional indirect-revenue exposure onto the consumer subscription core.

Short descriptiontext

Clue operates one of the world's largest female health applications for period, fertility, pregnancy, and perimenopause tracking, with 100M+ downloads across 190+ countries. Its freemium Clue app and Clue Plus subscription monetize through app stores, insurance partners, and wearable integrations.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersBerlin, Germany
HQ citystring
Berlin
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
period tracking app, fertility tracking, menstrual cycle tracking, digital contraceptive, women's health app
Industry2 codes
1Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration)
CodeHLACAPAIPrimaryYes
2Edge-Based Clinical Decision Support & Alerts (On-Device/On-Prem Analytics)
CodeHLACAPALPrimaryNo
Product category
Women's Health & Femtech Software
GTM motion6 records

Each record includes

Type, Description, Source

Revenue model4 records
1Clue Plus subscription
TypeSubscription Recurring
Description

Recurring premium subscription unlocking advanced cycle insights, pattern analysis, multiple tracking modes (Conceive, Pregnancy, Perimenopause), Clue Connect partner sharing, medical-expert content, and unlimited tracking customization. Sold directly via the iOS/Android apps (Apple App Store / Google Play) and via helloclue.com (processed through merchant of record Paddle).

helloclue.com
2Freemium (Clue Free)
TypeFreemium
Description

Free tier offering essential cycle statistics, basic cycle predictions, and account creation. Used as the top-of-funnel conversion driver into Clue Plus; no direct revenue from free users.

helloclue.com
3Insurance-covered subscription (B2B2C)
TypeSubscription Recurring
Description

B2B2C revenue via partnership with German private health insurer Süddeutsche Krankenversicherung (SDK) and Stuttgarter Lebensversicherung, where Clue Plus is provided at no extra cost to ~680,000 fully insured SDK members and ~1,600 employees — the world's first insurance-covered period and cycle tracker.

globenewswire.com
4HSA/FSA-funded subscription (US)
TypeSubscription Recurring
Description

US subscription payments processed through Flex, enabling Clue Plus to be paid with pre-tax HSA/FSA health dollars and unlocking 30–40% user savings. Web payments for FSA/HSA handled via Flex or its third-party processors.

helloclue.com
Marketing channels11 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels8 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations
Pricing details2 tiers
1Clue Free — free account with essential cycle stats and basic predictions
ModelFreemiumBilling cadencePay-as-you-go
Notes

Free; no payment required; full access to basic cycle tracking, essential cycle statistics, and basic cycle predictions.

helloclue.com
2Clue Plus Premium — paid tier unlocking advanced insights, multiple tracking modes, partner sharing, and expert content
ModelSubscriptionBilling cadenceMonthly
Notes

Recurring subscription billed via App Store/Play Store in-app and via helloclue.com (Paddle). Discounts include a 25% web offer banner (BANNER25 / PLANCTA25). Promotional three-month free trials of Clue Plus bundled with partner hardware purchases (e.g., Huawei HUAWEI WATCH FIT 5).

helloclue.com
GTM typeB2C
B2C
Offering typeSoftware
Software
Brand1 of 3 records shown
1Clue Birth Control
Description

FDA-cleared digital contraceptive that predicts pregnancy risk based on cycle data and clinical research.

balderton.com
+2 more records
Core offering1 text field

Clue is a mobile period, fertility, and cycle-tracking application (iOS and Android) that lets users log symptoms and predict periods, PMS, ovulation, and fertile windows. It operates on a freemium model, with the free Clue app providing basic tracking and Clue Plus offering advanced predictions, multiple life-stage modes (Conceive, Pregnancy, Perimenopause, No Period), expert content, and partner cycle sharing. Clue also offers Clue Birth Control, an FDA-cleared digital contraceptive in the US, and a CE-marked Clue Conceive fertility-prediction mode, all built on a privacy-first platform hosted on EU servers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • 100M+ app downloads worldwide across 190+ countries
+6 more records
Product overview1 text field

Clue is a single unified mobile application (iOS and Android) called Clue, developed by Biowink GmbH in Berlin, augmented by a premium subscription tier called Clue Plus that unlocks advanced cycle insights and additional tracking modes. The product architecture is one app with mode-based experiences on top: Clue (free period and cycle tracker), Clue Plus (premium insights, predictions, expert content, and Clue Connect sharing), Clue Conceive (CE-marked, clinically validated fertility/trying-to-conceive mode), Clue Pregnancy Mode (week-by-week pregnancy tracking), Clue Perimenopause (menopause transition tracking), and Clue No Period (cycle-related tracking without bleeding). On top of the app, Clue also offers Clue Birth Control (an FDA-cleared digital contraceptive in the US) and a Wearables integration layer that syncs biometric data from Oura, Withings, WHOOP, Ultrahuman, Huawei, Polar, Fitbit, Luna, and Noise into the Clue platform. Distribution is via the Apple App Store and Google Play Store, with Clue Plus subscriptions also sold through helloclue.com (processed by Paddle) and via FSA/HSA payments handled by Flex.

Product and service5 records
1Clue (Free Period & Cycle Tracker)
CategoryMobile health app
Description

Flagship free mobile app (iOS and Android) by Biowink GmbH that lets users log period dates, symptoms, moods, and physical experiences, and surfaces essential cycle statistics and basic cycle predictions. Marketed as women-led, science-based, and privacy-first, with 100M+ downloads across 190+ countries and 23 languages.

2Clue Plus
CategoryPremium subscription
Description

Premium subscription tier unlocked inside the Clue app that adds advanced cycle insights, personalized predictions and pattern analysis, switchable tracking modes for different life stages (Conceive, Pregnancy, Perimenopause, No Period), unlimited tracking customization, Clue Connect partner sharing, and unlimited access to medical-expert content. Sold via Apple App Store, Google Play, and helloclue.com (processed by Paddle).

3Clue Conceive
CategoryFertility tracking mode
Description

CE-marked, clinically validated fertility mode within the Clue app that uses a validated algorithm to identify a user's most fertile days, with daily pregnancy probability predictions, ovulation test result tracking, 200+ symptom tracking options, Oura Temperature sync, and Clue Connect partner sharing; designed for users trying to conceive.

4Clue Birth Control
CategoryFDA-regulated digital contraceptive
Description

FDA-cleared digital contraceptive in the US that predicts pregnancy risk based on cycle data and clinical research, built on top of the Clue period-tracking platform.

5Clue Wearables Integration
CategoryCross-platform biometric integration
Description

Cross-platform integration layer that syncs skin temperature, sleep duration, and other biometric data from partner wearables (Oura, Withings, Ultrahuman, WHOOP, Huawei, Polar, Fitbit, Luna, Noise) into Clue so users can combine continuous wearable data with cycle tracking for deeper insights into menstrual and hormonal patterns; also surfaced on smartwatches such as the HUAWEI WATCH FIT 5 Series.

Scale indicator15 records

Each record includes

Type, Value, Description, Source

Partnership27 partners
1Süddeutsche Krankenversicherung a.G. (SDK)
Strategic tierFlagshipTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-05-28
Description

SDK, one of Germany's leading private health insurers, partnered with Clue to make it the world's first period and menstrual cycle tracker covered by health insurance. SDK's ~680,000 fully insured members plus ~1,600 employees gain Clue Plus at no extra cost.

globenewswire.com
Strategic tierMajorTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-05-28
Description

German life insurer whose ~1,600 employees gain Clue Plus access at no extra cost as part of the SDK insurance partnership.

3Women's Health Visibility Alliance (Essity, Hertility, Daye, Mooncup)
Strategic tierMajorTypeGTM or Marketing PartnerAnnounced on2026-03-09
Description

Clue co-founded the Women's Health Visibility Alliance alongside Essity, Hertility, Daye, and Mooncup to challenge systemic social-media censorship of women's-health information, following a CensHERship-campaign open letter signed by 600+ women's-health leaders.

independent.co.uk
Strategic tierFlagshipTypeTechnology or IntegrationAnnounced on2025-12-17
Description

HSA/FSA payment-infrastructure provider Flex partnered with Clue to enable US consumers to use pre-tax health dollars for Clue Plus subscriptions, unlocking 30–40% user savings and expanding financial access to reproductive-health tools.

Strategic tierFlagshipTypeTechnology or IntegrationAnnounced on2025-11-17
Description

Huawei added Clue to the health and fitness ecosystem of the HUAWEI WATCH FIT 5 Series, integrating cycle tracking, biometric insights, and cycle-synced training plans into the smartwatch. Buyers receive a three-month free trial of Clue Plus as part of the launch promotion, and the integration is distributed via HUAWEI AppGallery.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2025-10-27
Description

NHS-licensed digital healthcare platform Evaro partnered with Clue to integrate NHS-funded contraception services within Clue's UK app — a UK-first integration — providing free, remote access to contraception and addressing UK access barriers. Evaro also secured €21M Series A funding with Clue named as a key partner.

Strategic tierFlagshipTypeTechnology or Integration
Description

Oura is one of Clue's women's-health partner platforms. Oura ring users can sync biometric data (temperature trends, sleep patterns, activity levels) with Clue for combined cycle tracking, fertility monitoring, and hormonal insights.

Strategic tierFlagshipTypeTechnology or Integration
Description

Apple Health integration allows users to sync health data between Clue and the Apple Health app on iOS, with explicit user-controlled permissions governing what personal data is exchanged.

Strategic tierFlagshipTypeTechnology or Integration
Description

Google Health Connect integration enables Android users to sync health data with the Clue app under user-controlled permissions, enabling bi-directional read/write of relevant health information.

Strategic tierMajorTypeTechnology or Integration
Description

WHOOP is part of Clue's expanded wearable integrations announced in November 2025, syncing wearable biometric data into Clue for menstrual and hormonal-pattern insights.

Strategic tierMajorTypeTechnology or Integration
Description

Withings is part of Clue's expanded wearable integrations announced in November 2025, syncing wearable biometric data into Clue for menstrual and hormonal-pattern insights.

Strategic tierMajorTypeTechnology or Integration
Description

Ultrahuman is part of Clue's expanded wearable integrations announced in November 2025, syncing wearable biometric data into Clue for menstrual and hormonal-pattern insights.

Strategic tierMajorTypeTechnology or Integration
Description

Polar is part of Clue's expanded wearable integrations announced in November 2025, syncing wearable biometric data into Clue for menstrual and hormonal-pattern insights.

Strategic tierMajorTypeTechnology or Integration
Description

Fitbit is part of Clue's expanded wearable integrations announced in November 2025, syncing wearable biometric data into Clue for menstrual and hormonal-pattern insights.

Strategic tierFlagshipTypeTechnology or Integration
Description

AWS EMEA SARL is Clue's hosting provider; Clue uses only AWS data centers in the European Union, with all data encrypted by Clue at rest.

Strategic tierFlagshipTypeTechnology or Integration
Description

Braze facilitates Clue's in-app messages, push notifications, and emails (newsletter, promotional, and Cycle Review emails), processing user data on EU servers under pseudonymization.

Strategic tierMajorTypeTechnology or Integration
Description

Datadog provides Clue with service and infrastructure monitoring and alerting, storing monitoring data on EU servers to help resolve application-performance issues quickly.

Strategic tierMajorTypeTechnology or Integration
Description

Firebase Cloud Messaging powers push notifications and alerts on the Android Clue app using device-specific push tokens.

Strategic tierMajorTypeTechnology or Integration
Description

Adjust (Germany-based) provides attribution and analytics for Clue's advertising campaigns, using IDFA/Google Play Services IDs and IP addresses, sharing install/subscribe events with ad networks like Meta and TikTok to suppress redundant ads.

Strategic tierFlagshipTypeTechnology or Integration
Description

Paddle is Clue's merchant of record for helloclue.com web subscriptions, processing payments and acting as the controller of payment data; Clue remains the controller of app usage data.

Strategic tierMajorTypeTechnology or Integration
Description

Apple's 'Sign in with Apple' service is offered as a Clue account login option, with strict limits on health data exchanged with Apple.

Strategic tierMajorTypeTechnology or Integration
Description

Google's 'Sign in with Google' service is offered as a Clue account login option, with strict limits on health data exchanged with Google.

Strategic tierMajorTypeTechnology or Integration
Description

Meta's 'Facebook Login' is offered as a Clue account login option, with strict limits on health data exchanged with Facebook.

Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Oxford is one of Clue's research partners, using de-identified Clue data to advance women's-health research and close the gender data gap.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Stanford is featured as one of Clue's research collaborators, with de-identified Clue data contributing to women's-health research.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Berkeley, MIT, and other leading institutions partner with Clue to advance women's-health research using Clue's real-world data.

Strategic tierMajorTypeGTM or Marketing Partner
Description

L'Oréal has partnered with Clue to integrate user-consented hormonal-cycle data into L'Oréal's product development, reflecting the broader femtech trend of linking hormonal data with consumer-health and beauty R&D.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Glow is a fertility and period tracking app that also extends into broader reproductive health (Glow Baby, Glow Nurture). Comparable to Clue's Conceive and Pregnancy modes and competes for the same trying-to-conceive and pregnancy-tracking user base.

TypeDirect peer
Description

Natural Cycles is an FDA-cleared digital contraceptive and fertility tracker with a CE-marked algorithm — directly comparable to Clue Birth Control and Clue Conceive. Both companies operate in regulated digital contraception, sell consumer subscriptions, and compete for the same 'trying to conceive / avoid pregnancy' user segment.

TypeDirect peer
Description

Flo Health is the largest direct competitor in period and fertility tracking, offering a freemium app with AI-driven personalised insights, pregnancy mode, and health insights. Both companies target the same primary consumer (women tracking cycles), operate global freemium subscription models, and compete head-to-head on App Store rankings.

TypeEmerging player
Description

Ava offers a hardware-enabled fertility tracker (the Ava bracelet) that combines wearables with cycle prediction. Comparable to Clue's wearable-integration strategy (Oura, Withings) and Clue Conceive, but with proprietary hardware instead of relying on partner OEMs.

5Daye
TypeEmerging player
Description

Daye is a women's-health startup offering tampons, CBD-based period care, and a vaginal microbiome screening kit, with an adjacent cycle-tracking experience. Co-founder of the Women's Health Visibility Alliance alongside Clue, making Daye both an ecosystem ally and an emerging femtech competitor in the UK/EU market.

TypeEmerging player
Description

Elvie is a women's health brand best known for connected breast pumps and pelvic-floor trainers, and is widely cited as a femtech peer in analyst reports alongside Clue. Both brands target women's-health-conscious consumers and operate premium hardware- and app-enabled product portfolios.

TypeOthers
Description

Oura is both a Clue wearable integration partner (syncing temperature trends and sleep data) and a women's-health platform in its own right. Oura could be considered a partner-and-potential-competitor: while Clue ingests Oura data today, Oura also ships native cycle insights directly to its ring users.

TypeDirect peer
Description

Ovia Health is a women's and family health platform offering period tracking, fertility, and pregnancy modes with strong US employer and health-plan B2B distribution. Comparable to Clue's consumer tracking experience and increasingly to Clue's insurance-covered distribution model via Ovia's employer benefits partnerships.

TypeOthers
Description

Withings is a Clue wearable integration partner that syncs skin temperature and sleep data into Clue, but also offers its own health-tracking ecosystem. Comparable as a complementary femtech hardware partner with potential to ship competing native cycle features on Withings devices.

TypeBroad incumbent
Description

Apple Health ships built-in cycle tracking, fertility insights, and HealthKit integration that competes with Clue's free and Clue Plus functionality for iOS users. Apple is also a critical distribution partner (App Store, Apple Watch), creating both a channel and a competitive threat for Clue.

Market position
Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment8 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile6 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration18 records

Each record includes

Title, Type, Description, Source

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds13 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors18 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Clue

Women's Health & Femtech Softwarehelloclue.com

Clue operates one of the world's largest female health applications for period, fertility, pregnancy, and perimenopause tracking, with 100M+ downloads across 190+ countries. Its freemium Clue app and Clue Plus subscription monetize through app stores, insurance partners, and wearable integrations.

What Clue does

Clue (legally BioWink GmbH, headquartered in Berlin, Germany) is a femtech company that operates one of the world's largest female health applications for period, fertility, pregnancy, and perimenopause tracking, with reported 100M+ downloads across 190+ countries and 23 languages. The platform is built around a single iOS/Android app with mode-based experiences (Period, Conceive, Pregnancy, Perimenopause, No-Period) plus an FDA-cleared digital contraceptive called Clue Birth Control and a CE-marked fertility algorithm in Clue Conceive, all backed by clinically validated predictive models and an in-app encyclopedia authored with OB/GYNs and certified fertility nurses. The technical stack runs on AWS EU servers under strict GDPR compliance, with health and personal data stored separately, no-sell/no-share-of-health-data guarantees, and de-identified data feeding research collaborations with Oxford, Berkeley, MIT, Stanford, and the Bill & Melinda Gates Foundation. The wearable layer ingests skin temperature and sleep data from 11+ OEM partners including Oura, Withings, WHOOP, Ultrahuman, Huawei, Polar, Fitbit, Luna, Noise, Apple Health, and Google Health Connect.

Clue's revenue model is freemium-led: the free Clue app serves as a top-of-funnel conversion driver into Clue Plus, a monthly subscription sold via App Store, Play Store, and helloclue.com (processed through Paddle) that unlocks advanced cycle insights, multiple tracking modes, Clue Connect partner sharing, and expert content. Paid acquisition extends beyond direct-to-consumer through three emerging B2B2C and channel-revenue streams: insurance-covered distribution via German private health insurer SDK and Stuttgarter Lebensversicherung (~680,000 fully insured members), pre-tax HSA/FSA payments via Flex in the US, and embedded NHS-funded contraception via Evaro in the UK. Brand and research partnerships (L'Oréal, the Women's Health Visibility Alliance with Essity/Hertility/Daye/Mooncup) and wearable OEM co-marketing (e.g., HUAWEI WATCH FIT 5 three-month trial) layer additional indirect-revenue exposure onto the consumer subscription core.

Clue firmographics

Firmographics
Name
Clue
Legal name
BioWink GmbH
Website
https://helloclue.com
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
51–100 employees
Short description
Clue operates one of the world's largest female health applications for period, fertility, pregnancy, and perimenopause tracking, with 100M+ downloads across 190+ countries. Its freemium Clue app and Clue Plus subscription monetize through app stores, insurance partners, and wearable integrations.
Ownership category
akta.pro rank

Clue industry classification

Industry
Product category
Women's Health & Femtech Software
akta.pro primary industry
Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI)
akta.pro secondary industry
Edge-Based Clinical Decision Support & Alerts (On-Device/On-Prem Analytics) (HLACAPAL)

Keywords

  • Period tracking app
  • Fertility tracking
  • Menstrual cycle tracking
  • Digital contraceptive
  • Women's health app

Where Clue is headquartered

Location

Headquarters

HQ city
Berlin
HQ country
Germany
HQ region
Europe

Offices1 record

Markets served

Clue business model

Business model
GTM type
B2C
Offering type
Software
Cost components
Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations

Revenue model

  1. Clue Plus subscription: Recurring premium subscription unlocking advanced cycle insights, pattern analysis, multiple tracking modes (Conceive, Pregnancy, Perimenopause), Clue Connect partner sharing, medical-expert content, and unlimited tracking customization. Sold directly via the iOS/Android apps (Apple App Store / Google Play) and via helloclue.com (processed through merchant of record Paddle).
  2. Freemium (Clue Free): Free tier offering essential cycle statistics, basic cycle predictions, and account creation. Used as the top-of-funnel conversion driver into Clue Plus; no direct revenue from free users.
  3. Insurance-covered subscription (B2B2C): B2B2C revenue via partnership with German private health insurer Süddeutsche Krankenversicherung (SDK) and Stuttgarter Lebensversicherung, where Clue Plus is provided at no extra cost to ~680,000 fully insured SDK members and ~1,600 employees — the world's first insurance-covered period and cycle tracker.
  4. HSA/FSA-funded subscription (US): US subscription payments processed through Flex, enabling Clue Plus to be paid with pre-tax HSA/FSA health dollars and unlocking 30–40% user savings. Web payments for FSA/HSA handled via Flex or its third-party processors.

Pricing tiers

ModelBillingPrice
FreemiumPay-as-you-goClue Free — free account with essential cycle stats and basic predictions
SubscriptionMonthlyClue Plus Premium — paid tier unlocking advanced insights, multiple tracking modes, partner sharing, and expert content

Go-to-market motion6 records

Distribution channels8 records

Marketing channels11 records

Clue product offering

Product offering

Core offering

Clue is a mobile period, fertility, and cycle-tracking application (iOS and Android) that lets users log symptoms and predict periods, PMS, ovulation, and fertile windows. It operates on a freemium model, with the free Clue app providing basic tracking and Clue Plus offering advanced predictions, multiple life-stage modes (Conceive, Pregnancy, Perimenopause, No Period), expert content, and partner cycle sharing. Clue also offers Clue Birth Control, an FDA-cleared digital contraceptive in the US, and a CE-marked Clue Conceive fertility-prediction mode, all built on a privacy-first platform hosted on EU servers.

Product overview

Clue is a single unified mobile application (iOS and Android) called Clue, developed by Biowink GmbH in Berlin, augmented by a premium subscription tier called Clue Plus that unlocks advanced cycle insights and additional tracking modes. The product architecture is one app with mode-based experiences on top: Clue (free period and cycle tracker), Clue Plus (premium insights, predictions, expert content, and Clue Connect sharing), Clue Conceive (CE-marked, clinically validated fertility/trying-to-conceive mode), Clue Pregnancy Mode (week-by-week pregnancy tracking), Clue Perimenopause (menopause transition tracking), and Clue No Period (cycle-related tracking without bleeding). On top of the app, Clue also offers Clue Birth Control (an FDA-cleared digital contraceptive in the US) and a Wearables integration layer that syncs biometric data from Oura, Withings, WHOOP, Ultrahuman, Huawei, Polar, Fitbit, Luna, and Noise into the Clue platform. Distribution is via the Apple App Store and Google Play Store, with Clue Plus subscriptions also sold through helloclue.com (processed by Paddle) and via FSA/HSA payments handled by Flex.

Differentiator

Problem solved

Functional benefit

Brands

  • Clue Birth Control: FDA-cleared digital contraceptive that predicts pregnancy risk based on cycle data and clinical research.
  • Clue Plus
  • Clue Conceive

Products and services

  • Clue (Free Period & Cycle Tracker) Flagship free mobile app (iOS and Android) by Biowink GmbH that lets users log period dates, symptoms, moods, and physical experiences, and surfaces essential cycle statistics and basic cycle predictions. Marketed as women-led, science-based, and privacy-first, with 100M+ downloads across 190+ countries and 23 languages.
  • Clue Plus Premium subscription tier unlocked inside the Clue app that adds advanced cycle insights, personalized predictions and pattern analysis, switchable tracking modes for different life stages (Conceive, Pregnancy, Perimenopause, No Period), unlimited tracking customization, Clue Connect partner sharing, and unlimited access to medical-expert content. Sold via Apple App Store, Google Play, and helloclue.com (processed by Paddle).
  • Clue Conceive CE-marked, clinically validated fertility mode within the Clue app that uses a validated algorithm to identify a user's most fertile days, with daily pregnancy probability predictions, ovulation test result tracking, 200+ symptom tracking options, Oura Temperature sync, and Clue Connect partner sharing; designed for users trying to conceive.
  • Clue Birth Control FDA-cleared digital contraceptive in the US that predicts pregnancy risk based on cycle data and clinical research, built on top of the Clue period-tracking platform.
  • Clue Wearables Integration Cross-platform integration layer that syncs skin temperature, sleep duration, and other biometric data from partner wearables (Oura, Withings, Ultrahuman, WHOOP, Huawei, Polar, Fitbit, Luna, Noise) into Clue so users can combine continuous wearable data with cycle tracking for deeper insights into menstrual and hormonal patterns; also surfaced on smartwatches such as the HUAWEI WATCH FIT 5 Series.

Quantifiable outcome

  • 100M+ app downloads worldwide across 190+ countries
  • +6 more outcomes

Companies that use Clue

Customer profile

Named customers3 records

Segments8 records

Ideal customer profiles6 records

Clue technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration18 records

AI capability5 records

Feature6 records

Clue partnerships and signals

Strategic signal

Partnerships

27 partnerships are on record, tiered flagship and major.

  • Süddeutsche Krankenversicherung a.G. (SDK)flagshipChannel Partner/ Reseller/ Distributor · 28 May 2026SDK, one of Germany's leading private health insurers, partnered with Clue to make it the world's first period and menstrual cycle tracker covered by health insurance. SDK's ~680,000 fully insured members plus ~1,600 employees gain Clue Plus at no extra cost.
  • Stuttgarter Lebensversicherung a.G.majorChannel Partner/ Reseller/ Distributor · 28 May 2026German life insurer whose ~1,600 employees gain Clue Plus access at no extra cost as part of the SDK insurance partnership.
  • Women's Health Visibility Alliance (Essity, Hertility, Daye, Mooncup)majorGTM or Marketing Partner · 9 March 2026Clue co-founded the Women's Health Visibility Alliance alongside Essity, Hertility, Daye, and Mooncup to challenge systemic social-media censorship of women's-health information, following a CensHERship-campaign open letter signed by 600+ women's-health leaders.
  • FlexflagshipTechnology or Integration · 17 December 2025HSA/FSA payment-infrastructure provider Flex partnered with Clue to enable US consumers to use pre-tax health dollars for Clue Plus subscriptions, unlocking 30–40% user savings and expanding financial access to reproductive-health tools.
  • HuaweiflagshipTechnology or Integration · 17 November 2025Huawei added Clue to the health and fitness ecosystem of the HUAWEI WATCH FIT 5 Series, integrating cycle tracking, biometric insights, and cycle-synced training plans into the smartwatch. Buyers receive a three-month free trial of Clue Plus as part of the launch promotion, and the integration is distributed via HUAWEI AppGallery.
  • EvaroflagshipStrategic or Co-development Partner · 27 October 2025NHS-licensed digital healthcare platform Evaro partnered with Clue to integrate NHS-funded contraception services within Clue's UK app — a UK-first integration — providing free, remote access to contraception and addressing UK access barriers. Evaro also secured €21M Series A funding with Clue named as a key partner.
  • OuraflagshipTechnology or IntegrationOura is one of Clue's women's-health partner platforms. Oura ring users can sync biometric data (temperature trends, sleep patterns, activity levels) with Clue for combined cycle tracking, fertility monitoring, and hormonal insights.
  • Apple Health (iOS)flagshipTechnology or IntegrationApple Health integration allows users to sync health data between Clue and the Apple Health app on iOS, with explicit user-controlled permissions governing what personal data is exchanged.
  • Google Health Connect (Android)flagshipTechnology or IntegrationGoogle Health Connect integration enables Android users to sync health data with the Clue app under user-controlled permissions, enabling bi-directional read/write of relevant health information.
  • WHOOPmajorTechnology or IntegrationWHOOP is part of Clue's expanded wearable integrations announced in November 2025, syncing wearable biometric data into Clue for menstrual and hormonal-pattern insights.
  • WithingsmajorTechnology or IntegrationWithings is part of Clue's expanded wearable integrations announced in November 2025, syncing wearable biometric data into Clue for menstrual and hormonal-pattern insights.
  • UltrahumanmajorTechnology or IntegrationUltrahuman is part of Clue's expanded wearable integrations announced in November 2025, syncing wearable biometric data into Clue for menstrual and hormonal-pattern insights.
  • PolarmajorTechnology or IntegrationPolar is part of Clue's expanded wearable integrations announced in November 2025, syncing wearable biometric data into Clue for menstrual and hormonal-pattern insights.
  • FitbitmajorTechnology or IntegrationFitbit is part of Clue's expanded wearable integrations announced in November 2025, syncing wearable biometric data into Clue for menstrual and hormonal-pattern insights.
  • Amazon Web Services (AWS)flagshipTechnology or IntegrationAWS EMEA SARL is Clue's hosting provider; Clue uses only AWS data centers in the European Union, with all data encrypted by Clue at rest.
  • BrazeflagshipTechnology or IntegrationBraze facilitates Clue's in-app messages, push notifications, and emails (newsletter, promotional, and Cycle Review emails), processing user data on EU servers under pseudonymization.
  • DatadogmajorTechnology or IntegrationDatadog provides Clue with service and infrastructure monitoring and alerting, storing monitoring data on EU servers to help resolve application-performance issues quickly.
  • Firebase Cloud Messaging (Google)majorTechnology or IntegrationFirebase Cloud Messaging powers push notifications and alerts on the Android Clue app using device-specific push tokens.
  • AdjustmajorTechnology or IntegrationAdjust (Germany-based) provides attribution and analytics for Clue's advertising campaigns, using IDFA/Google Play Services IDs and IP addresses, sharing install/subscribe events with ad networks like Meta and TikTok to suppress redundant ads.
  • PaddleflagshipTechnology or IntegrationPaddle is Clue's merchant of record for helloclue.com web subscriptions, processing payments and acting as the controller of payment data; Clue remains the controller of app usage data.
  • Apple (Sign in with Apple)majorTechnology or IntegrationApple's 'Sign in with Apple' service is offered as a Clue account login option, with strict limits on health data exchanged with Apple.
  • Google (Sign in with Google)majorTechnology or IntegrationGoogle's 'Sign in with Google' service is offered as a Clue account login option, with strict limits on health data exchanged with Google.
  • Facebook / Meta (Facebook Login)majorTechnology or IntegrationMeta's 'Facebook Login' is offered as a Clue account login option, with strict limits on health data exchanged with Facebook.
  • University of OxfordflagshipStrategic or Co-development PartnerOxford is one of Clue's research partners, using de-identified Clue data to advance women's-health research and close the gender data gap.
  • Stanford UniversitymajorStrategic or Co-development PartnerStanford is featured as one of Clue's research collaborators, with de-identified Clue data contributing to women's-health research.
  • University of California, Berkeley (MIT)majorStrategic or Co-development PartnerBerkeley, MIT, and other leading institutions partner with Clue to advance women's-health research using Clue's real-world data.
  • L'OréalmajorGTM or Marketing PartnerL'Oréal has partnered with Clue to integrate user-consented hormonal-cycle data into L'Oréal's product development, reflecting the broader femtech trend of linking hormonal data with consumer-health and beauty R&D.

Scale indicators15 records

Recent moves6 records

Expansion highlights6 records

Clue competitors and assessment

Company assessment

Direct peers

  • Glow: Glow is a fertility and period tracking app that also extends into broader reproductive health (Glow Baby, Glow Nurture). Comparable to Clue's Conceive and Pregnancy modes and competes for the same trying-to-conceive and pregnancy-tracking user base.
  • Natural Cycles: Natural Cycles is an FDA-cleared digital contraceptive and fertility tracker with a CE-marked algorithm — directly comparable to Clue Birth Control and Clue Conceive. Both companies operate in regulated digital contraception, sell consumer subscriptions, and compete for the same 'trying to conceive / avoid pregnancy' user segment.
  • Flo Health: Flo Health is the largest direct competitor in period and fertility tracking, offering a freemium app with AI-driven personalised insights, pregnancy mode, and health insights. Both companies target the same primary consumer (women tracking cycles), operate global freemium subscription models, and compete head-to-head on App Store rankings.
  • Ovia Health: Ovia Health is a women's and family health platform offering period tracking, fertility, and pregnancy modes with strong US employer and health-plan B2B distribution. Comparable to Clue's consumer tracking experience and increasingly to Clue's insurance-covered distribution model via Ovia's employer benefits partnerships.

Emerging players

  • Ava Science: Ava offers a hardware-enabled fertility tracker (the Ava bracelet) that combines wearables with cycle prediction. Comparable to Clue's wearable-integration strategy (Oura, Withings) and Clue Conceive, but with proprietary hardware instead of relying on partner OEMs.
  • Daye: Daye is a women's-health startup offering tampons, CBD-based period care, and a vaginal microbiome screening kit, with an adjacent cycle-tracking experience. Co-founder of the Women's Health Visibility Alliance alongside Clue, making Daye both an ecosystem ally and an emerging femtech competitor in the UK/EU market.
  • Elvie: Elvie is a women's health brand best known for connected breast pumps and pelvic-floor trainers, and is widely cited as a femtech peer in analyst reports alongside Clue. Both brands target women's-health-conscious consumers and operate premium hardware- and app-enabled product portfolios.

Others

  • Oura: Oura is both a Clue wearable integration partner (syncing temperature trends and sleep data) and a women's-health platform in its own right. Oura could be considered a partner-and-potential-competitor: while Clue ingests Oura data today, Oura also ships native cycle insights directly to its ring users.
  • Withings: Withings is a Clue wearable integration partner that syncs skin temperature and sleep data into Clue, but also offers its own health-tracking ecosystem. Comparable as a complementary femtech hardware partner with potential to ship competing native cycle features on Withings devices.

Broad incumbents

  • Apple (Health): Apple Health ships built-in cycle tracking, fertility insights, and HealthKit integration that competes with Clue's free and Clue Plus functionality for iOS users. Apple is also a critical distribution partner (App Store, Apple Watch), creating both a channel and a competitive threat for Clue.

Market position

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Clue social profiles

Digital presence

Clue compliance and trust

Trust signal

Compliance4 records

Clue financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Clue leadership team

Management profile

Number of profiles

Profiles11 records

Clue funding detail

Funding detail

Funding overview

Funding rounds13 records

Investors18 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Clue M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Clue

What does Clue do?

Clue is a mobile period, fertility, and cycle-tracking application (iOS and Android) that lets users log symptoms and predict periods, PMS, ovulation, and fertile windows. It operates on a freemium model, with the free Clue app providing basic tracking and Clue Plus offering advanced predictions, multiple life-stage modes (Conceive, Pregnancy, Perimenopause, No Period), expert content, and partner cycle sharing. Clue also offers Clue Birth Control, an FDA-cleared digital contraceptive in the US, and a CE-marked Clue Conceive fertility-prediction mode, all built on a privacy-first platform hosted on EU servers.

Is Clue a public or private company?

Clue is a private company. It is classified as venture growth investor backed and is currently operating.

When was Clue founded?

Clue was founded in 2012. It employs 51 to 100 people.

Where is Clue based?

Clue is headquartered in Berlin, Germany, in the Europe region.

How does Clue make money?

Four revenue lines are on record. Clue Plus subscription is the primary driver. The others are freemium (Clue Free), insurance-covered subscription (B2B2C) and HSA/FSA-funded subscription (US).

Who are Clue's main competitors?

Direct peers on record are Glow, Natural Cycles, Flo Health and Ovia Health. Emerging players are Ava Science, Daye and Elvie. Others are Oura and Withings. Apple (Health) is listed as a broad incumbent.

Does Clue have an API?

No public API is recorded for Clue.

What industry is Clue in?

Clue's product category is Women's Health & Femtech Software. Its primary akta.pro industry code is HLACAPAI, Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration), with a secondary code of HLACAPAL, Edge-Based Clinical Decision Support & Alerts (On-Device/On-Prem Analytics).

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
MobiHealthNewsFlora Fertility, Clue partner on fertility planningFlora Fertility partnered with Clue to connect fertility insurance with cycle-tracking, with Clue members learning about Flora's coverage and Flora policyholders receiving Clue Plus access. Flora's policies offer up to $50,000 in future fertility coverage, including diagnostics, medications, and IVF.PR NewswireFEMTECH LEADERS FLORA FERTILITY AND CLUE PARTNER TO ADVANCE FERTILITY EDUCATION AND ACCESSFlora Fertility and Clue announced a partnership to advance fertility education and access. Clue Plus subscribers will get up to $50,000 in future fertility coverage through Flora. The collaboration aims to reach women earlier in their reproductive planning.StartupmafiaBest FemTech Startups of 2026Twelve femtech startups are highlighted for 2026, including Clue, Natural Cycles, and Flo Health, with global funding projected to top $1.8B across 2024–2026. Europe, led by Germany, France, the UK, and the Nordics, is a key testing ground. The trend shifts from tracking apps to reimbursable diagnostics, devices, and care infrastructure.FinancialContent Business PageNew Research using Clue Data Suggests Menstrual Cycle Timing May Influence Vaccine Side EffectsResearchers from the London School of Hygiene & Tropical Medicine and the University of Montpellier published a study in npj Women's Health using Clue app menstrual tracking data to investigate whether COVID-19 vaccination timing within the menstrual cycle affects vaccine outcomes. The study of 1,474 Clue users found that those vaccinated during the follicular phase had 35% higher odds of reporting any vaccine side effect compared with those vaccinated during the luteal phase, with no evidence of more severe effects. The researchers emphasize the findings should not be used to time vaccination, as receiving a vaccine when available remains far more important than cycle timing, though they support including menstrual cycle phase as a variable in future vaccine research.GlobeNewswireNew Research using Clue Data Suggests Menstrual Cycle Timing May Influence Vaccine Side EffectsResearchers at London School of Hygiene & Tropical Medicine and University of Montpellier, in collaboration with Oregon Health & Science University and Clue, published a study in npj Women's Health finding that women vaccinated during the follicular phase of their menstrual cycle had 35% higher odds of reporting vaccine side effects compared to those vaccinated during the luteal phase. The study, which used Clue's menstrual tracking data from 1,474 users, also found that follicular-phase participants went a median of 35 days longer before subsequent COVID-19 infection, though researchers emphasize this finding is exploratory. The researchers stress that the findings should not be used to time vaccination, as receiving a vaccine when available remains far more important than cycle timing.Financial PostShe Had No Clue, Until She Did: Clue's new campaign spotlights seven women who found the missing piece behind years of symptoms, questions and hormonal uncertaintyClue, a women's health tracking app, launched a new marketing campaign titled 'She Had No Clue, Until She Did' featuring seven women who used the app to identify hormonal health conditions including PMDD, adenomyosis, and fertility challenges. The campaign highlights moments when women connected long-standing symptoms to hormonal patterns after years of dismissed concerns. Louise Troen, Clue's Chief Marketing Officer, stated the campaign aims to help more women feel less alone in their health experiences.FinancialContent Business PageShe Had No Clue, Until She Did: Clue's new campaign spotlights seven women who found the missing piece behind years of symptoms, questions and hormonal uncertaintyClue, a women-led period and cycle tracking app with over 100 million users globally, launched a new brand campaign titled 'She Had No Clue, Until She Did' featuring seven members sharing how cycle and symptom tracking helped them get diagnoses for conditions like PMDD, adenomyosis, and PMOS, and gain better understanding of their hormonal health.GlobeNewswireShe Had No Clue, Until She Did: Clue's new campaign spotlights seven women who found the missing piece behind years of symptoms, questions and hormonal uncertaintyClue, a women's health app company, has launched a new marketing campaign titled 'She Had No Clue, Until She Did,' featuring seven women who used the app to track their cycles and ultimately gain diagnoses or better understanding of hormonal health conditions including PMDD, PMOS, and adenomyosis. The campaign, rolled out across Clue's channels from late June through films and storytelling content, aims to highlight how data-driven tracking can help women connect previously dismissed symptoms to medical conditions. Clue reports that over 100 million people globally use its platform to track periods, fertility, pregnancy, and perimenopause.FinancialContent Business PageTwentyeight Health partners with Clue to expand access to affordable birth control nationwideTwentyeight Health, a women's telehealth platform, announced a partnership with Clue, a menstrual and reproductive health app trusted by millions, enabling US-based Clue users to access personalized birth control counseling from Twentyeight Health's nationwide network of licensed providers and receive prescriptions online with home or pharmacy delivery. The partnership closes the gap between cycle tracking and accessing prescription care, building on Twentyeight Health's Complete Care model that covers approximately 50 million women through over 500 commercial and Medicaid insurance partners. Both companies prioritize HIPAA-compliant data security and user consent for health information sharing.GlobeNewswireTwentyeight Health partners with Clue to expand access to affordable birth control nationwideTwentyeight Health, a women's telehealth platform, announced a partnership with Clue, a menstrual and reproductive health app, enabling US-based Clue users to access personalized birth control counseling from Twentyeight Health's network of licensed providers. Users can receive online prescriptions when clinically appropriate and have medications delivered to their door or a local pharmacy, with services covered by insurance at standard copays or available for $9.99 per month out-of-pocket. The partnership expands Twentyeight Health's Complete Care model, which covers approximately 50 million women through over 500 commercial and Medicaid insurance partners nationwide.